Novovartalon
In our Mexican pharmacy, you can buy Novovartalon at a dosage of 1500 mg. In the package of 15 envelopes for the preparation of the solution. The medication is taken orally.
Novovartalon (Glucosamine, Meloxican) belongs to the group of non-steroidal anti-inflammatory and anti-rheumatic drugs, correctors of bone and cartilage tissue metabolism. The main active substance is glucosamine sulfate in a dosage of 1500 mg. The drug stimulates the synthesis of glucosaminoglycan and proteoglycan of cartilage, and also increases the formation of hyaluronic acid in the synovial fluid.
The absolute bioavailability of Novovartalon in humans after oral administration was 44%, taking into account the effect of the first passage through the liver. It does not bind to plasma proteins. The half-life is 15 hours. Glucosamine is mainly metabolized by conversion to hexosamine, regardless of the cytochrome system.
Indications for use
Novovartalon is used as an additional treatment and is a biological supplement. It is prescribed for the treatment of patients with the following diseases:
• Arthrosis
• Degenerative diseases of the joints and spine
• Impaired joint mobility
• Sprain, strain on joints
• Violation of the synthesis of joint fluid
• Osteoarthrosis
• Osteochandrosis
• Systemic inflammation (C-reactive protein) in healthy overweight people
• Functional and morphological damage to the matrix, due to the use of corticosteroids
The drug is also used to relieve pain in arthrosis and osteoarthritis.
Contraindications Novovartalon
Contraindications to the use of Novovartalon are:
• Hypersensitivity to glucosamine sulfate
• Phenylketonuria
• Children under 15 years of age (due to insufficient information on the study of the drug in children)
• First trimester of pregnancy
• Lactation
After the first trimester, Novovartalon is used only if the risk to the mother exceeds the risk to the fetus.
Interaction with other drugs
Novovartalon enhances intestinal absorption of tetracycline drugs. Reduces intestinal absorption of chloramphenicol and penicillin antibiotics.
The medication has a synergistic effect while taking it with non-steroidal anti-inflammatory drugs. In particular, it enhances the anti-inflammatory and analgesic effects of NSAIDs. Reduces the negative effect of corticosteroids on cartilage.Side effects
The drug may have the following side effects:
• epigastric pain
• constipation, diarrhea, flatulence, nausea
• skin reactions caused by hypersensitivity to the drug
• headache, drowsiness
If any symptoms appear, consult your doctor. You may need either a dosage reduction or drug withdrawal.
Dosage and administration
Novovartalon take 1 packet dissolved in water - 1 time per day, preferably with a meal. The duration of the course is from 2 to 4 weeks. Next, take a break for 2 months and start the course again.
A clinical trial was conducted over 3 years, so taking the drug for more than this period is not recommended.
Special recommendations for the use of the drug
Novovartalon is prescribed as a long-term therapy and is not a fast-acting pain medication for intense pain. Patients with bronchial asthma should take the supplement with caution, because of the possible exacerbation of symptoms.
Patients with diabetes should take a more thorough glucose measurement; insulin dosage adjustment may be necessary. In case of renal or hepatic insufficiency, Novovartalon therapy should be carried out under the supervision of a doctor.
If drowsiness and headache have developed due to the use of the drug, one should refrain from driving a vehicle and controlling dangerous mechanisms.
NOVOVARTALON Formulation and Dosage Form Each sachet contains: Glucosamine Sulfate polycrystalline equivalent to 1,500 mg of glucosamine sulfate Meloxicam 15 mg Dosage and administration NOVOVARTALON ® is administered orally. It is particularly useful in patients diagnosed with osteoarthritis in the acute phase is accompanied by pain and / or stiffness. INDICATIONS: Condroprotector and analgesic. Glucosamine has been classified by the International League Against Rheumatism (ILAR) and the EULAR (European League Against Rheumatism) as a symptomatic slow-acting drug for osteoarthritis (SYSADOA), but also for its therapeutic action, also it has been classified as disease modifying drug stops the progression of osteoarthritis (DMOAD). Meloxicam is a non steroidal anti-inflammatory selective COX-2, indicated in the treatment of inflammation and pain present in osteoarthritis (degenerative joint disease), periarthritis of shoulder, hip and knee. Therefore, the association NOVOVARTALON® glucosamine-Meloxicam is clear indication in the population with the following risk factors: age 50 years, obesity, people who play high-impact sports to the joints, patients with a history of trauma or fractures involving the joints. The chondroprotective and restorative effect of glucosamine, coupled with its symptomatic action, modifies the evolution of osteoarthritis, which added to the anti-inflammatory and analgesic action of meloxicam significantly relieve pain, both at rest and during movement, improving mobility short and medium term. The association of meloxicam NOVOVARTALON® glucosamine provides a quick symptomatic action and initiates the process of suspending the progression of osteoarthritis.
Leave your review